한국인 대상의 PPARGC1A 유전적 다형성과 제2형 당뇨병과의 상관성
Association between PPARGC1A Genetic Polymorphisms and Type 2 Diabetes Mellitus in the Korean Population
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
제2형 당뇨병(T2DM)과 그 유병률은 전세계적으로 증가하고 있다. T2DM은 인슐린 저항성이 높아지고 인슐린 분비가 감소해 발생하는 당뇨병의 가장 흔한 유형 중 하나다. 과산화물 증식활성수용체 감마 공활성제 1 알파(PPARGC1A)는 미토콘드리아 생물 발생의 마스터 조절기와 간에서 포도당신합성에 관여한다. 본 연구에서는 T2DM이 있는 한국인 중년층의 PPARGC1A 유전자의 유전적 다형성을 분석하였다. 그 결과, PPARGC1A 유전자 중 15개의 SNP가 T2DM과 통계적으로 유의한 연관성을 보였으며, 그 중 PPARGC1A 유전자의 rs10212638은T2DM (P=0.015, OR=1.29, CI=1.05∼1.59)과 통계적으로가장 큰 유의한 상관관계를 보였다. PPARGC1A의 마이너 유전자형(minor allele) G는 T2DM의 위험을 증가시켰다. 본 연구는 T2DM와 PPARGC1A의 유전적 다형성 사이에 유의한 연관성을 보여주고 있다. 이러한 결과는PPARGC1A의 SNP가T2DM의 병의 원인이 되는 유전적 연관성이 있음을 시사한다.
Abstract
The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. T2DM is one of the most common types of diabetes and is caused by increased insulin resistance and reduced insulin secretion. Peroxisome proliferator-activated receptor γ coactivator 1 alpha (PPARGC1A) is a master modulator of mitochondrial biogenesis and of gluconeogenesis in liver. In this study, we analyzed genetic polymorphisms of PPARGC1A gene in a middle-aged Korean population with T2DM. Using the genotype data of 736 T2DM cases and 4544 healthy controls obtained from the Korean Association Resource (KARE), we analyzed genetic correlations between single nucleotide polymorphisms (SNPs) of PPARGC1A and T2DM. Fifteen SNPs of PPARGC1A demonstrated a statistically significant association with T2DM. Of these, rs10212638 exhibited the strongest correlation with T2DM (P-value=0.015, OR=1.29, CI=1.05∼1.59), and the minor G allele of PPARGC1A increased the risk of T2DM. This is the first study to report a significant association between genetic polymorphisms in PPARGC1A and T2DM and suggests that SNPs of PPARGC1A display genetic correlations to the etiology of T2DM.
참고문헌 (17)
- Nadeau KJ, "Youth-onset type 2 diabetes consensus report : current status, challenges, and priorities", Diabetes Care, 39, pp.1635~1642 (2016)[DOI]
- Shaw JE, "Type 2 diabetes worldwide according to the new classification and criteria", Diabetes Care, 23, pp.B5~B10 (2000)
- Yoon JC, "Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1", Nature, 413, pp.131~138 (2001)[DOI]
- Cho YS, "A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits", Nat Genet, 41, pp.527~534 (2009)[DOI]
- Qiu L, "Molecular characterization, tissue expression and polymorphisms of buffalo PPARGC1A gene", Arch Anim Breed, 63, pp.249~259 (2020)[DOI]
- Esterbauer H, "Human per-oxisome proliferator activated receptor gamma coactivator 1(PPARGC1)gene : cDNA sequence, genomic organization, chro-mosomal localization, and tissue expression", Genomics, 62, pp.98~102 (1999)[DOI]
- Puigserver P, "A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis", Cell, 92, pp.829~839 (1998)[DOI]
- Joanne Clark, "Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson's disease", BMC Medical Genetics, 12(1), pp.69~ (2011), Springer Science and Business Media LLC[DOI]
- Che HV, "Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease", Mol Neurodegener, 6, pp.1~ (2011)[DOI]
- Salazar G, "SQSTM1", p62 and PPARGC1A, Autophagy, pp.2020, 16[DOI]
- Soyal S, "PGC-1 alpha : a po-tent transcriptional cofactor involved in the pathogenesis of type 2 diabetes", Diabetologia, 49, pp.1477~1488 (2006)[DOI]
- Zhu Li, "PPARGC1A rs3736265 G＞A polymorphism is associated with de-creased risk of type 2 diabetes mellitus and fasting plasma glu-cose level", Oncotarget, 8, pp.37308~37320 (2017)[DOI]
- Park S, "Interaction effect of PGC-1α rs10517030variants and energy intake in the risk of type 2 diabetes in mid-dle-aged adults", Eur J Clin Nutr, 71, pp.1442~1448 (2017)[DOI]
- Totomoch-Serra A, "Association of common polymorphisms in the VEGFA and SIRT1 genes with type 2 diabetes-related traits in Mexicans", Arch Med Sci, 14, pp.1361~1373 (2018)[DOI]
- Cheema AK, "Genetic associations of PPARGC1A with type 2 diabetes : differ-ences among populations with African origins", J Diabetes Res, 2015, pp.921274~ (2015)[DOI]
- Lehmann JM, "An antidiabetic thiazolidinedione is a high affin-ity ligand for peroxisome proliferator-activated receptor γ(PPAR γ)", J Biol Chem, 270, pp.12953~12956 (1995)[DOI]
- Kim JH, "Peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population", Diabetologia, 48, pp.1323~1330 (2005)[DOI]